Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-22 4:03 pm Purchase |
2024-03-12 | 13G | Regulus Therapeutics Inc. RGLS |
Deep Track Capital, LP | 6,888,424 9.990% |
6,888,424 (New Position) |
Filing History |
| 2024-03-22 4:02 pm Purchase |
2024-03-14 | 13G | Cybin Inc. CYBN |
Deep Track Capital, LP | 1,529,988 7.650% |
1,529,988 (New Position) |
Filing History |
| 2024-03-15 4:08 pm Purchase |
2024-03-07 | 13G | Mind Medicine (MindMed) Inc. MNMD |
Deep Track Capital, LP | 6,666,667 9.490% |
6,666,667 (New Position) |
Filing History |
| 2024-03-08 4:03 pm Purchase |
2024-02-27 | 13G | Pyxis Oncology, Inc. PYXS |
Deep Track Capital, LP | 4,184,100 7.870% |
4,184,100 (New Position) |
Filing History |
| 2024-02-23 4:48 pm Purchase |
2024-02-14 | 13G | enGene Holdings Inc. Common Stock ENGN |
Deep Track Capital, LP | 2,250,000 5.210% |
2,250,000 (New Position) |
Filing History |
| 2024-02-14 11:33 am Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Deep Track Capital, LP | 3,649,726 9.620% |
-34,893 (-0.95%) |
Filing History |
| 2024-02-14 11:32 am Sale |
2023-12-31 | 13G | 89bio, Inc. ETNB |
Deep Track Capital, LP | 2,000,000 2.100% |
-2,331,499 (-53.83%) |
Filing History |
| 2024-02-14 11:31 am Unchanged |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.880% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:02 am Unchanged |
2023-12-31 | 13G | Zura Bio Limited ZURA |
Deep Track Capital, LP | 4,205,000 9.290% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:01 am Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 5,378,997 9.900% |
2,066,023 (+62.36%) |
Filing History |
| 2024-02-14 08:59 am Sale |
2023-12-31 | 13G | Valneva SE VALN |
Deep Track Capital, LP | 7,526,807 5.420% |
-2,986,458 (-28.41%) |
Filing History |
| 2024-02-14 08:58 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 7,522,281 9.990% |
2,940,281 (+64.17%) |
Filing History |
| 2024-02-14 08:57 am Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Deep Track Capital, LP | 6,100,000 9.870% |
2,540,000 (+71.35%) |
Filing History |
| 2024-02-14 08:56 am Purchase |
2023-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 2,184,440 6.030% |
1,894,118 (+652.42%) |
Filing History |
| 2024-02-14 08:56 am Purchase |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 4,063,676 5.530% |
809,544 (+24.88%) |
Filing History |
| 2024-02-14 08:55 am Unchanged |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 5,854,740 5.430% |
0 (Unchanged) |
Filing History |
| 2024-02-14 08:54 am Purchase |
2023-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,992,731 7.100% |
265,125 (+9.72%) |
Filing History |
| 2024-02-14 08:53 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,044,507 6.790% |
-793,311 (-27.95%) |
Filing History |
| 2024-02-14 08:52 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,793,966 5.220% |
-197,437 (-9.91%) |
Filing History |
| 2024-02-14 08:52 am Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Deep Track Capital, LP | 5,750,000 9.600% |
2,645,493 (+85.21%) |
Filing History |